A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120-Reference-Cited by-同舟云学术

A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120

Published:2007-04 Issue:2 Volume:360 Page:329-340
ISSN:0042-6822
Container-title:Virology
language:en
Short-container-title:Virology

Author:

Beddows Simon,Franti Michael,Dey Antu K.,Kirschner Marc,Iyer Sai Prasad N.,Fisch Danielle C.,Ketas Thomas,Yuste Eloisa,Desrosiers Ronald C.,Klasse Per Johan,Maddon Paul J.,Olson William C.,Moore John P.

Publisher

Elsevier BV

Subject

Virology

Reference53 articles.

1. Human immunodeficiency virus type 1 Env with an intersubunit disulfide bond engages coreceptors but requires bond reduction after engagement to induce fusion;Abrahamyan;J. Virol.,2003

2. The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region;Barnett;J. Virol.,2001

3. Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1;Beddows;J. Virol.,2005

4. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease;Berger;Annu. Rev. Immunol.,1999

5. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure;Binley;J. Virol.,2000

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2;Journal of Controlled Release;2021-02

2. Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike;2020-07-02

3. A Prime-Boost Immunization Strategy with Vaccinia Virus Expressing Novel gp120 Envelope Glycoprotein from a CRF02_AG Isolate Elicits Cross-Clade Tier 2 HIV-1 Neutralizing Antibodies;Vaccines;2020-04-07

4. Innovations in HIV-1 Vaccine Design;Clinical Therapeutics;2020-03

5. HIV-1-Based Virus-like Particles that Morphologically Resemble Mature, Infectious HIV-1 Virions;Viruses;2019-06-02